Guggenheim Floating Rate Strategies Fund (Institutional Class) returned 0.92% (1.28% gross) in the fourth quarter of 2025. Read more here.

Core Bond Fund returned 1.00% in Q4, trailing its benchmark. Read our full analysis of market trends and economic projections ...

Guggenheim analyst Subbu Nambi reiterated a Buy rating on Illumina yesterday and set a price target of $170.00. The company’s shares closed yesterday at $133.61.

The Guggenheim announced plans for its U.A.E. location back in 2006. Rendering of the Frank Gehry-designed Guggenheim Abu Dhabi. Photo courtesy Tourism Development and Investment Company and Gehry ...

A link to the live and archived webcast may be accessed on the Unicycive website under the Investors section: Events and Presentations. To schedule a 1x1 meeting with management, please contact your ...

There’s good news on the horizon for design fans: the long-awaited Guggenheim Museum in Abu Dhabi looks all set to open in 2025. With legendary architect and design extraordinaire Frank Gehry at the ...

About Solid Biosciences Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, ...

Guggenheim analyst Michael Schmidt reiterated a Buy rating on Tango Therapeutics yesterday and set a price target of $18.00. The company’s shares closed yesterday at $11.95.

GULF and the Illuminator, action at the Guggenheim Museum (2016) (All photos by the author for Hyperallergic) Last night, in a visually dazzling act of public protest, the artist-activist groups ...

Shares of Avalo Therapeutics Inc (NASDAQ:AVTX) climbed about 5.8% in premarket trading on Monday after Guggenheim launched ...

AtaiBeckley Inc. (NASDAQ:ATAI) is one of the best fast growing penny stocks to buy according to analysts. On January 20, Guggenheim initiated coverage of AtaiBeckley with a Buy rating and an $11 price ...